Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07699367
EARLY_PHASE1

Metformin and ACLR Muscle Recovery

Sponsor: University of Utah

View on ClinicalTrials.gov

Summary

The purpose of this research study is to determine if Metformin taken after anterior cruciate ligament reconstruction (ACLR) surgery can decrease muscle fibrosis, cellular senescence and improve leg strength. ACL injury and surgery increase muscle collagen content and inflammation which slows the recovery of muscle and function and ultimately impacts the quality of life. Individuals enrolled in the study will be randomized to receive metformin (or placebo) for 4 months after surgery. The investigators will measure muscle strength and inflammatory markers in muscle biopsy samples after the intervention period. Investigators will also follow up with participants 8 months later to determine the lasting effects of the intervention.

Official title: Metformin and Muscle Recovery Following ACL Surgery

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2026-11-01

Completion Date

2032-10-01

Last Updated

2026-07-13

Healthy Volunteers

No

Interventions

DRUG

Metformin

Individuals randomized to the metformin group will take metformin daily (up to 2grams/day) for 4 months following ACLR surgery.

OTHER

Placebo

Individuals randomized to the placebo will take the same number of pills as the metformin group daily over a 4 month period following ACLR surgery.

Locations (1)

University of Utah

Salt Lake City, Utah, United States